Epimerasedeficiency

Epimerasedeficiency is a proposed rare metabolic disorder caused by deficiency of enzymes that catalyze epimerization of sugars in nucleotide-sugar pools used for glycosylation and related pathways. In human metabolism, epimerases help convert one sugar epimer to another, a step that supports the synthesis of glycoproteins, glycolipids, and proteoglycans. When epimerase activity is reduced, abnormalities in glycosylation and carbohydrate metabolism may arise, potentially affecting multiple organ systems.

Pathophysiology is linked to impaired production and remodeling of nucleotide-sugars, which can disrupt glycosylation patterns essential for protein folding, cell signaling, and membrane function. The resulting biochemical disturbances may contribute to liver dysfunction, growth delay, hypotonia, developmental challenges, and coagulation abnormalities in affected individuals. Because the condition is extremely rare and poorly characterized, the full spectrum of organ involvement remains uncertain.

Genetically, most available reporting suggests an autosomal recessive pattern, consistent with many congenital enzyme deficiencies, but data are limited. Documented cases (when present) rely on reduced epimerase activity in enzymatic assays and identification of biallelic variants in genes encoding nucleotide-sugar epimerases, with confirmatory genetic testing aiding diagnosis.

Diagnosis rests on a combination of clinical assessment, biochemical evaluation of glycosylation status, specific enzyme activity assays, and genetic testing. Differential diagnosis includes other congenital disorders of glycosylation and carbohydrate metabolism disorders.

Management is supportive and multidisciplinary, focusing on optimizing nutrition, monitoring liver and developmental health, and managing metabolic complications. Due to limited case data, no standardized treatment guidelines exist, and prognosis is largely contingent on early identification and the extent of organ involvement. Ongoing research aims to define natural history and therapeutic options.